Associated tags: Organic, International, Nutrition, Government, Life, NGO, Pharma, Pharmaceutical industry, Medication, Kangaroo care, Supermarket, Infant formula, Care, FDA, Lactoferrin, Immune system, Absorption, Parent, GMO, Health, Food, Nutrient, TerryWhite Chemmart, Infant, Migraine, Woolworths Supermarkets
Locations: US
Retrieved on:
Tuesday, September 26, 2023
Pharma,
Migraine,
Partnership,
Administration,
NDA,
Record,
Pain,
MD,
Patient,
Nausea,
Pharmaceutical industry MIAMI, Sept. 26, 2023 /PRNewswire/ -- Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch of RizaFilm® for Q1-2024.
Key Points:
- MIAMI, Sept. 26, 2023 /PRNewswire/ -- Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch of RizaFilm® for Q1-2024.
- As the NDA holder, Gensco® will begin commercialization of the 10mg Film and will continue to fund the expanded indications for the 5mg Pediatric dose.
- RizaFilm® is a film formulation of rizatriptan and the only oral dissolvable film available for the treatment of acute migraines.
- The switch to RizaFilm® is seamless, as it is prescribed the same way as current rizatriptan, but in a Film form.
Retrieved on:
Thursday, February 2, 2023
Caregiver,
Science,
Formula,
Pharma,
Breast milk,
Criticism of the Food and Drug Administration,
Woolworths Supermarkets,
TerryWhite Chemmart,
Infant,
Medication,
Nutrient,
Food,
Health,
GMO,
Parent,
Absorption,
Immune system,
Lactoferrin,
Partnership,
FDA,
Care,
Infant formula,
Supermarket,
Kangaroo care,
Dietary supplement,
Pharmaceutical industry DORAL, Fla., Feb. 2, 2023 /PRNewswire/ -- Amid a continuing supply chain crisis in the U.S. baby formula market, Australian health and wellness company, Care A2 Plus Pty Ltd ('Care'), and American Pharmaceutical Company, Gensco® Pharma, have announced a partnership to bring the already established Australian Infant formula into millions of American homes.
Key Points:
- DORAL, Fla., Feb. 2, 2023 /PRNewswire/ -- Amid a continuing supply chain crisis in the U.S. baby formula market, Australian health and wellness company, Care A2 Plus Pty Ltd ('Care'), and American Pharmaceutical Company, Gensco® Pharma, have announced a partnership to bring the already established Australian Infant formula into millions of American homes.
- The Food and Drug Administration the U.S., certifying that the Australian-made Care A2+ Infant Formula meets the standards set by the FDA.
- In early January 2023 the FDA extended the approval for Care A2+ to be sold in the US to October 2025.
- Care A2+ is sold through major Australian retailers Woolworths Supermarkets and major Pharmaceutical outlets - Chemist Warehouse and Terry White Chemists.
